跳至主要内容
临床试验/NCT01834066
NCT01834066Unknown1 期

Safety and Efficacy of Bone Marrow Autologous Cells in Muscular Dystrophy. It is Self Funded (Patients' Own Funding) Clinical Trial

Chaitanya Hospital, Pune2 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2014年9月1日最近更新:
适应症

试验速览

阶段
1 期
发起方
入组人数
25
试验地点
2
主要终点
Significant Improvement in Muscle strength by using Kinetics Muscle testing or by using MMT( manual muscle test }score

研究概览

简要总结

This Study is single arm, single centre trial to check the safety and efficacy of Bone Marrow derived autologous cell(100 million per dose) for the patient with Duchenne Muscular Dystrophy.

详细描述

Muscular dystrophy is a group of inherited disorders that involve muscle weakness and loss of muscle tissue, which get worse over time. Duchenne muscular dystrophy is caused by a defective gene for dystrophin (a protein in the muscles). However, it often occurs in people without a known family history of the condition. slowly progress diseases.it causes Muscle weaknesses, Difficulty with motor skills ,Progressive difficulty walking.Breathing difficulties and heart disease,Frequent falls,weak limbs,lose motor Function.Begins in the legs and pelvis, but also occurs less severely in the arms, neck, and other areas of the body.Trouble getting up from a lying position or climbing stairs.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
6 Years 至 25 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Patient with Diagnose of Duchenne Muscular Dystrophy.
  • Aged in between 6 to 25 Years.
  • Willingness to undergo Bone Marrow derived Autologous cell Therapy.
  • Ability to comprehend the explained protocol and thereafter give an informed consent as well as sign the required Informed Consent form(ICF) for the study.
  • Ability and willingness to regular visit to hospital for protocol procedures and follow up

排除标准

  • Patient who is not Diagnose of Duchenne Muscular Dystrophy.
  • Patient with History of Immunodeficiency HIV+,Hepatitis B ,HBV and TPPA+,Tumor Markers+
  • History of Life threatening allergic or immune -Mediated Reaction.
  • the site of bone marrow aspiration potentially limiting Procedure.
  • Alcohol and drug abuse / dependence.
  • Patients with History of Hypertension and Hypersensitive.

结局指标

主要结局

Significant Improvement in Muscle strength by using Kinetics Muscle testing or by using MMT( manual muscle test }score

时间窗: 6 Months

次要结局

  • -Improvement of daily living scale and baseline in EMG(electromyography)(6 months)

研究者

发起方
Chaitanya Hospital, Pune
申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. Sachin Jamadar

C0- Investigator

Chaitanya Hospital, Pune

研究点 (2)

Loading locations...

相似试验